Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4354 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Liver Cancer |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Liver Cancer Peripheral Blood Mononuclear Cells are isolated from the peripheral blood of patients with liver cancer, mainly including lymphocytes (T cells, B cells, NK cells) and monocytes. PBMCs play a central role in immune regulation, among which cytotoxic T cells and NK cells can recognize and eliminate tumor cells, while regulatory T cells (Tregs) may inhibit anti-tumor immune responses and promote liver cancer progression. Monocytes can differentiate into tumor-associated macrophages (TAMs) and participate in the formation of the tumor microenvironment. In hepatocellular carcinoma (HCC), alterations in the composition and function of PBMCs are closely related to disease progression, such as T cell exhaustion, NK cell function inhibition, and expansion of immunosuppressive cells, leading to immune escape.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Liver Cancer Peripheral Blood Mononuclear Cells can be used to study immune escape mechanisms in the liver cancer microenvironment, such as T cell exhaustion, NK cell activity inhibition, and expansion of immunosuppressive cells (such as Treg and MDSCs). These cells can also be used to evaluate the efficacy of immunotherapy (such as PD-1/PD-L1 inhibitors, CAR-T cell therapy).